Apoptosis and in vitro Alzheimer’s disease neuronal  models

References

• Selkoe DJ. Alzheimer's disease: genes, proteins and therapy. Physiol Rev 2001; 81:741 - 766
   PubMed Web of Science ®Google Scholar
• Shen Y, He P, Zhong Z, McAllister C, Lindholm K. Distinct destructive signal pathways of neuronal death in Alzheimer's disease. Trends Mol Med 2006; 12:574 - 579
   PubMed Web of Science ®Google Scholar
• Salehi A, Delcroix JD, Mobley WC. Traffic at the intersection of neurotrophic factor signaling and neurodegeneration. Trends Neurosci 2003; 26:73 - 80
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002; 297:353 - 356
   PubMed Web of Science ®Google Scholar
• Blurton-Jones M, Laferla FM. Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res 2006; 3:437 - 448
   PubMedGoogle Scholar
• Mattson MP. Apoptosis in neurodegenerative disorders. Nat Rev Mol Cell Biol 2000; 1:120 - 129
   PubMed Web of Science ®Google Scholar
• Mattson MP, Magnus T. Ageing and neuronal vulnerability. Nat Rev Neurosci 2006; 7:278 - 294
   PubMed Web of Science ®Google Scholar
• Schulte-Herbrüggen O, Braun A, Rochlitzer S, Jockers-Scherübl MC, Hellweg R. Neurotrophic factors—a tool for therapeutic strategies in neurological, neuropsychiatric and neuroimmunological diseases?. Curr Med Chem 2007; 14:2318 - 2329
   PubMed Web of Science ®Google Scholar
• Canu N, Calissano P. In vitro cultured neurons for molecular studies correlating apoptosis with events related to Alzheimer disease. Cerebellum 2003; 2:270 - 278
   PubMed Web of Science ®Google Scholar
• Shimohama S. Apoptosis in Alzheimer's disease—an update. Apoptosis 2000; 5:9 - 16
   PubMed Web of Science ®Google Scholar
• Behl C. Apoptosis and Alzheimer's disease. J Neural Transm 2000; 107:1325 - 1344
   PubMed Web of Science ®Google Scholar
• Kitamura Y, Shimohama S, Kamoshima W, Ota T, Matsuoka Y, Nomura Y, et al. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease. Brain Res 1998; 780:260 - 269
   PubMed Web of Science ®Google Scholar
• Su JH, Deng G, Cotman CW. Bax protein expression is increased in Alzheimer's brain: correlations with DNA damage, Bcl-2 expression and brain pathology. J Neuropathol Exp Neurol 1997; 56:86 - 93
   PubMed Web of Science ®Google Scholar
• Stadelmann C, Deckwerth TL, Srinivasan A, Bancher C, Brück W, Jellinger K, et al. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. Am J Pathol 1999; 155:1459 - 1466
   PubMed Web of Science ®Google Scholar
• Selznick LA, Holtzman DM, Han BH, Gökden M, Srinivasan AN, Johnson EM Jr, et al. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. J Neuropathol Exp Neurol 1999; 58:1020 - 1026
   PubMed Web of Science ®Google Scholar
• Guo H, Albrecht S, Bourdeau M, Petzke T, Bergeron C, LeBlanc AC. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques and neurofibrillary tangles of Alzheimer's disease. Am J Pathol 2004; 165:523 - 531
   PubMed Web of Science ®Google Scholar
• Rohn TT, Head E, Nesse WH, Cotman CW, Cribbs DH. Activation of caspase-8 in the Alzheimer's disease brain. Neurobiol Dis 2001; 8:1006 - 1016
   PubMed Web of Science ®Google Scholar
• Rohn TT, Rissman RA, Davis MC, Kim YE, Cotman CW, Head E. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Caspase-9 activation and caspase cleavage of tau in the Alzheimer's disease brain. Neurobiol Dis 2002; 11:341 - 354
   PubMed Web of Science ®Google Scholar
• Wu CK, Thal L, Pizzo D, Hansen L, Masliah E, Geula C. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease. Exp Neurol 2005; 195:484 - 496
   PubMed Web of Science ®Google Scholar
• Albrecht S, Bourdeau M, Bennett D, Mufson EJ, Bhattacharjee M, LeBlanc AC. Activation of caspase-6 in aging and mild cognitive impairment. Am J Pathol 2007; 170:1200 - 1209
   PubMed Web of Science ®Google Scholar
• Suzuki T, Nishiyama K, Yamamoto A, Inazawa J, Iwaki T, Yamada T, et al. Molecular cloning of a novel apoptosis-related gene, human Nap1 (NCKAP1), and its possible relation to Alzheimer disease. Genomics 2000; 63:246 - 254
   PubMed Web of Science ®Google Scholar
• Cribbs DH, Poon WW, Rissman RA, Blurton-Jones M. Caspase-mediated degeneration in Alzheimer's disease. Am J Pathol 2004; 165:353 - 355
   PubMed Web of Science ®Google Scholar
• Gastard MC, Troncoso JC, Koliatsos VE. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease. Ann Neurol 2003; 54:393 - 398
   PubMed Web of Science ®Google Scholar
• Louneva N, Cohen JW, Han LY, Talbot K, Wilson RS, Bennett DA , et al. Caspase 3 is enriched in postsynaptic densities and increased in Alzheimer's disease. Am J Pathol 2008; 173:1488 - 1495
   PubMed Web of Science ®Google Scholar
• Su JH, Kesslak JP, Head E, Cotman CW. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain. Acta Neuropathol 2002; 104:1 - 6
   PubMed Web of Science ®Google Scholar
• Wai MS, Liang Y, Shi C, Cho EY, Kung HF, Yew DT. Co-localization of hyperphosphorylated tau and caspases in the brainstem of Alzheimer's disease patients. Biogerontology 2008; In press
   PubMed Web of Science ®Google Scholar
• Gervais FG, Xu D, Robertson GS, Vaillancourt JP, Zhu Y, Huang J, et al. Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell 1999; 97:395 - 406
   PubMed Web of Science ®Google Scholar
• Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, et al. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 2000; 6:397 - 404
   PubMed Web of Science ®Google Scholar
• Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M, et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 2007; 54:721 - 737
   PubMed Web of Science ®Google Scholar
• Marín N, Romero B, Bosch-Morell F, Llansola M, Felipo V, Romá J, et al. Beta-amyloid-induced activation of caspase-3 in primary cultures of rat neurons. Mech Ageing Dev 2000; 119:63 - 67
   PubMed Web of Science ®Google Scholar
• Loo DT, Copani A, Pike CJ, Whittemore ER, Walencewicz AJ, Cotman CW. Apoptosis is induced by beta-amyloid in cultured nervous system neurons. Proc Natl Acad Sci USA 1993; 90:7951 - 7955
   PubMed Web of Science ®Google Scholar
• Uetsuki T, Takemoto K, Nishimura I, Okamoto M, Niinobe M, Momoi T, et al. Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J Neurosci 1999; 19:6955 - 6964
   PubMed Web of Science ®Google Scholar
• Nishimura I, Uetsuki T, Kuwako K, Hara T, Kawakami T, Aimoto S, et al. Cell death induced by a caspase-cleaved transmembrane fragment of the Alzheimer amyloid precursor protein. Cell Death Differ 2002; 9:199 - 208
   PubMed Web of Science ®Google Scholar
• Chan SL, Mattson MP. Caspase and calpain substrates: roles in synaptic plasticity and cell death. J Neurosci Res 1999; 58:167 - 190
   PubMed Web of Science ®Google Scholar
• Glabe C. Intracellular mechanisms of amyloid accumulation and pathogenesis in Alzheimer's disease. J Mol Neurosci 2001; 17:137 - 145
   PubMed Web of Science ®Google Scholar
• Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, et al. Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 2003; 39:409 - 421
   PubMed Web of Science ®Google Scholar
• Lustbader JW, Cirilli M, Lin C, Xu HW, Takuma K, Wang N, et al. ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease. Science 2004; 304:448 - 452
   PubMed Web of Science ®Google Scholar
• Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, et al. Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation and ameliorates learning and memory in Alzheimer's disease. Nat Med 2008; 14:1097 - 1105
   PubMed Web of Science ®Google Scholar
• Oddo S. The ubiquitin-proteasome system in Alzheimer's disease. J Cell Mol Med 2008; 12:363 - 373
   PubMed Web of Science ®Google Scholar
• Song S, Lee H, Kam TI, Tai ML, Lee JY, Noh JY, et al. E2-25K/Hip-2 regulates caspase-12 in ER stress-mediated Abeta neurotoxicity. J Cell Biol 2008; 82:675 - 684
   Web of Science ®Google Scholar
• Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 2000; 403:98 - 103
   PubMed Web of Science ®Google Scholar
• Ivins KJ, Thornton PL, Rohn TT, Cotman CW. Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8. Neurobiol Dis 1999; 6:440 - 449
   PubMed Web of Science ®Google Scholar
• Giovanni A, Keramaris E, Morris EJ, Hou ST, O'Hare M, Dyson N, et al. E2F1 mediates death of B-amyloid-treated cortical neurons in a manner independent of p53 and dependent on Bax and caspase 3. J Biol Chem 2000; 275:11553 - 11560
   PubMed Web of Science ®Google Scholar
• Troy CM, Rabacchi SA, Friedman WJ, Frappier TF, Brown K, Shelanski ML. Caspase-2 mediates neuronal cell death induced by beta-amyloid. J Neurosci 2000; 20:1386 - 1392
   PubMed Web of Science ®Google Scholar
• Wei Z, Song MS, MacTavish D, Jhamandas JH, Kar S. Role of calpain and caspase in beta-amyloid-induced cell death in rat primary septal cultured neurons. Neuropharmacology 2008; 54:721 - 733
   PubMed Web of Science ®Google Scholar
• LeBlanc A, Liu H, Goodyer C, Bergeron C, Hammond J. Caspase-6 role in apoptosis of human neurons, amyloidogenesis and Alzheimer's disease. J Biol Chem 1999; 274:23426 - 23436
   PubMed Web of Science ®Google Scholar
• Weidemann A, Paliga K, Dürrwang U, Reinhard FB, Schuckert O, Evin G, et al. Proteolytic processing of the Alzheimer's disease amyloid precursor protein within its cytoplasmic domain by caspase-like proteases. J Biol Chem 1999; 274:5823 - 5829
   PubMed Web of Science ®Google Scholar
• Abrahamson EE, Ikonomovic MD, Ciallella JR, Hope CE, Paljug WR, Isanski BA, et al. Caspase inhibition therapy abolishes brain trauma-induced increases in Abeta peptide: implications for clinical outcome. Exp Neurol 2006; 197:437 - 450
   PubMed Web of Science ®Google Scholar
• Hook VY, Kindy M, Hook G. Inhibitors of cathepsin B improve memory and reduce beta-amyloid in transgenic Alzheimer disease mice expressing the wild-type, but not the Swedish mutant, beta-secretase site of the amyloid precursor protein. J Biol Chem 2008; 283:7745 - 7753
   PubMed Web of Science ®Google Scholar
• Trinchese F, Fa' M, Liu S, Zhang H, Hidalgo A, Schmidt SD, et al. Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease. J Clin Invest 2008; 118:2796 - 2807
   PubMed Web of Science ®Google Scholar
• Dickson DW. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?. J Clin Invest 2004; 114:23 - 27
   PubMed Web of Science ®Google Scholar
• García-Sierra F, Mondragón-Rodríguez S, Basurto-Islas G. Truncation of tau protein and its pathological significance in Alzheimer's disease. J Alzheimers Dis 2008; 14:401 - 409
   PubMed Web of Science ®Google Scholar
• Cotman CW, Poon WW, Rissman RA, Blurton-Jones M. The role of caspase cleavage of tau in Alzheimer disease neuropathology. J Neuropathol Exp Neurol 2005; 64:104 - 112
   PubMed Web of Science ®Google Scholar
• Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, et al. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci USA 2003; 100:10032 - 10037
   PubMed Web of Science ®Google Scholar
• Cho JH, Johnson GV. Glycogen synthase kinase 3 beta induces caspase-cleaved tau aggregation in situ. J Biol Chem 2004; 279:54716 - 54723
   PubMed Web of Science ®Google Scholar
• Fasulo L, Ugolini G, Visintin M, Bradbury A, Brancolini C, Verzillo V, et al. The neuronal microtubule-associated protein tau is a substrate for caspase-3 and an effector of apoptosis. J Neurochem 2000; 75:624 - 633
   PubMed Web of Science ®Google Scholar
• Chung CW, Song YH, Kim IK, Yoon WJ, Ryu BR, Jo DG, et al. Proapoptotic effects of tau cleavage product generated by caspase-3. Neurobiol Dis 2001; 8:162 - 172
   PubMed Web of Science ®Google Scholar
• Ramalho RM, Viana RJ, Castro RE, Steer CJ, Low WC, Rodriguez CM. Apoptosis in transgenic mice expressing the P301L mutated form of human tau. Mol Med 2008; 1485:309 - 317
   Google Scholar
• Rohn TT, Vyas V, Hernandez-estrada T, Nichol KE, Christie LA, Head E. Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the antiapoptotic protein bcl-2. J Neurosci 2008; 28:3051 - 3059
   PubMed Web of Science ®Google Scholar
• Zilkova M, Koson P, Zilka N. The hunt for dying neurons: insight into the neuronal loss in Alzheimer's disease. Bratisl Lek Listy 2006; 107:366 - 373
   PubMedGoogle Scholar
• Yuan J. Divergence from a dedicated cellular suicide mechanism: exploring the evolution of cell death. Mol Cell 2006; 23:1 - 12
   PubMed Web of Science ®Google Scholar
• Bredesen DE, Rao RV, Mehlen P. Cell death in the nervous system. Nature 2006; 443:796 - 802
   PubMed Web of Science ®Google Scholar
• D'Mello SR, Galli C, Ciotti T, Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci USA 1993; 90:10989 - 10993
   PubMed Web of Science ®Google Scholar
• Galli C, Meucci O, Scorziello A, Werge TM, Calissano P, Schettini G. Apoptosis in cerebellar granule cells is blocked by high KCl, forskolin and IGF-1 through distinct mechanisms of action: the involvement of intracellular calcium and RNA synthesis. J Neurosci 1995; 15:1172 - 1179
   PubMed Web of Science ®Google Scholar
• Borsello T, Di Luzio A, Ciotti MT, Calissano P, Galli C. Granule neuron DNA damage following deafferentation in adult rats cerebellar cortex: a lesion model. Neuroscience 2000; 95:163 - 171
   PubMed Web of Science ®Google Scholar
• Nardi N, Avidan G, Daily D, Zilkha-Falb R, Barzilai A. Biochemical and temporal analysis of events associated with apoptosis induced by lowering the extracellular potassium concentration in mouse cerebellar granule neurons. J Neurochem 1997; 68:750 - 759
   PubMed Web of Science ®Google Scholar
• Schulz JB, Beinroth S, Weller M, Wüllner U, Klockgether T. Endonucleolytic DNA fragmentation is not required for apoptosis of cultured rat cerebellar granule neurons. Neurosci Lett 1998; 245:9 - 12
   PubMed Web of Science ®Google Scholar
• Armstrong RC, Aja TJ, Hoang KD, Gaur S, Bai X, Alnemri ES, Litwack G, Karanewsky DS, Fritz LC, Tomaselli KJ. Activation of the CED3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J Neurosci 1997; 17:553 - 562
   PubMed Web of Science ®Google Scholar
• Eldadah BA, Yakovlev AG, Faden AI. The role of CED-3-related cysteine proteases in apoptosis of cerebellar granule cells. J Neurosci 1997; 17:6105 - 6113
   PubMed Web of Science ®Google Scholar
• Eldadah BA, Ren RF, Faden AI. Ribozyme-mediated inhibition of caspase-3 protects cerebellar granule cells from apoptosis induced by serum-potassium deprivation. J Neurosci 2000; 20:179 - 186
   PubMed Web of Science ®Google Scholar
• D'Mello SR, Kuan CY, Flavell RA, Rakic P. Caspase-3 is required for apoptosis-associated DNA fragmentation but not for cell death in neurons deprived of potassium. J Neurosci Res 2000; 59:24 - 31
   PubMed Web of Science ®Google Scholar
• Gerhardt E, Kügler S, Leist M, Beier C, Berliocchi L, Volbracht C, et al. Cascade of caspase activation in potassium-deprived cerebellar granule neurons: targets for treatment with peptide and protein inhibitors of apoptosis. Mol Cell Neurosci 2001; 4:717 - 731
   Web of Science ®Google Scholar
• Canu N, Dus L, Barbato C, Ciotti MT, Brancolini C, Rinaldi AM, et al. Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 1998; 18:7061 - 7074
   PubMed Web of Science ®Google Scholar
• Canu N, Tufi R, Serafino AL, Amadoro G, Ciotti MT, Calissano P. Role of the autophagic-lysosomal system on low potassium-induced apoptosis in cultured cerebellar granule cells. J Neurochem 2005; 92:1228 - 1242
   PubMed Web of Science ®Google Scholar
• Kaasik A, Rikk T, Piirsoo A, Zharkovsky T, Zharkovsky A. Upregulation of lysosomal cathepsin L and autophagy during neuronal death induced by reduced serum and potassium. Eur J Neurosci 2005; 22:1023 - 1031
   PubMed Web of Science ®Google Scholar
• Amadoro G, Pieri M, Ciotti MT, Carunchio I, Canu N, Calissano P, et al. Substance P provides neuroprotection in cerebellar granule cells through Akt and MAPK/Erk activation: evidence for the involvement of the delayed rectifier potassium current. Neuropharmacology 2007; 52:1366 - 1377
   PubMed Web of Science ®Google Scholar
• Kubo T, Nonomura T, Enokido Y, Hatanaka H. Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture. Brain Res Dev Brain Res 1995; 85:249 - 258
   PubMedGoogle Scholar
• D'Mello SR, Borodezt K, Soltoff SP. Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J Neurosci 1997; 17:1548 - 1560
   PubMed Web of Science ®Google Scholar
• Journot L, Villalba M, Bockaert J. PACAP-38 protects cerebellar granule cells from apoptosis. Ann NY Acad Sci 1998; 865:100 - 110
   PubMed Web of Science ®Google Scholar
• Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275:661 - 665
   PubMed Web of Science ®Google Scholar
• Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, et al. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 1999; 96:857 - 868
   PubMed Web of Science ®Google Scholar
• Kienlen Campard P, Crochemore C, René F, Monnier D, Koch B, Loeffler JP. DNA PACAP type I receptor activation promotes cerebellar neuron survival through the cAMP/PKA signaling pathway. Cell Biol 1997; 16:323 - 333
   Web of Science ®Google Scholar
• Villalba M, Bockaert J, Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 1997; 17:83 - 90
   PubMed Web of Science ®Google Scholar
• Galli C, Piccini A, Ciotti MT, Castellani L, Calissano P, Zaccheo D, et al. Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis. Proc Natl Acad Sci USA 1998; 95:1247 - 1252
   PubMed Web of Science ®Google Scholar
• Piccini A, Ciotti MT, Vitolo OV, Calissano P, Tabaton M, Galli C. Endogenous APP derivatives oppositely modulate apoptosis through an autocrine loop. Neuroreport 2000; 11:1375 - 1379
   PubMed Web of Science ®Google Scholar
• De Berardinis M, Ciotti MT, Amadoro G, Galli C, Calissano P. Transfer of the apoptotic message in sister cultures of cerebellar neurons. Neuroreport 2001; 12:2137 - 2140
   PubMed Web of Science ®Google Scholar
• Atlante A, Gagliardi S, Marra E, Calissano P. Neuronal apoptosis in rats is accompanied by rapid impairment of cellular respiration and is prevented by scavengers of reactive oxygen species. Neurosci Lett 1998; 245:127 - 130
   PubMed Web of Science ®Google Scholar
• Atlante A, Bobba A, Calissano P, Passarella S, Marra E. The apoptosis/necrosis transition in cerebellar granule cells depends on the mutual relationship of the antioxidant and the proteolytic systems which regulate ROS production and cytochrome c release en route to death. J Neurochem 2003; 84:960 - 971
   PubMed Web of Science ®Google Scholar
• Atlante A, Passarella S. Detection of reactive oxygen species in primary cultures of cerebellar granule cells. Brain Res Brain Res Protoc 1999; 4:266 - 270
   PubMedGoogle Scholar
• Schulz JB, Weller M, Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci 1996; 16:4696 - 4706
   PubMed Web of Science ®Google Scholar
• Levi-Montalcini R. Nerve growth Factor. Science 1975; 187:113
   PubMed Web of Science ®Google Scholar
• Boissière F, Hunot S, Faucheux B, Hersh LB, Agid Y, Hirsch EC. Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease. Dement Geriatr Cogn Disord 1997; 8:1 - 8
   PubMed Web of Science ®Google Scholar
• Chu Y, Cochran EJ, Bennett DA, Mufson EJ, Kordower JH. Downregulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 2001; 437:296 - 307
   PubMed Web of Science ®Google Scholar
• Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ. Downregulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 2006; 97:475 - 487
   PubMed Web of Science ®Google Scholar
• Mufson EJ, Lavine N, Jaffar S, Kordower JH, Quirion R, Saragovi HU. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp Neurol 1997; 146:91 - 103
   PubMed Web of Science ®Google Scholar
• Mufson EJ, Ma SY, Cochran EJ, Bennett DA, Beckett LA, Jaffar S, et al. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J Comp Neurol 2000; 427:19 - 30
   PubMedGoogle Scholar
• Salehi A, Verhaagen J, Dijkhuizen PA, Swaab DF. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 1996; 75:373 - 387
   PubMed Web of Science ®Google Scholar
• Counts SE, Nadeem M, Wuu J, Ginsberg SD, Saragovi HU, Mufson EJ. Reduction of cortical TrkA but not p75(NTR) protein in early-stage Alzheimer's disease. Ann Neurol 2004; 56:520 - 531
   PubMed Web of Science ®Google Scholar
• Hock C, Heese K, Hulette C, Rosenberg C, Otten U. Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 2000; 57:846 - 851
   PubMed Web of Science ®Google Scholar
• Savaskan E, Müller-Spahn F, Olivieri G, Bruttel S, Otten U, Rosenberg C, et al. Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur Neurol 2000; 44:172 - 180
   PubMed Web of Science ®Google Scholar
• Costantini C, Weindruch R, Della Valle G, Puglielli L. A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J 2005; 391:59 - 67
   PubMed Web of Science ®Google Scholar
• Costantini C, Scrable H, Puglielli L. An aging pathway controls the TrkA to p75NTR receptor switch and amyloid beta-peptide generation. EMBO J 2006; 25:1997 - 2006
   PubMed Web of Science ®Google Scholar
• Costantini C, Rossi F, Formaggio E, Bernardoni R, Cecconi D, Della-Bianca V. Characterization of the signaling pathway downstream p75 neurotrophin receptor involved in beta-amyloid peptide-dependent cell death. J Mol Neurosci 2005; 25:141 - 156
   PubMed Web of Science ®Google Scholar
• Schliebs R. Basal forebrain cholinergic dysfunction in Alzheimer's disease—interrelationship with beta-amyloid, inflammation and neurotrophin signaling. Neurochem Res 2005; 30:895 - 908
   PubMed Web of Science ®Google Scholar
• Yeo TT, Chua-Couzens J, Butcher LL, Bredesen DE, Cooper JD, Valletta JS, et al. Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation. J Neurosci 1997; 17:7594 - 7605
   PubMed Web of Science ®Google Scholar
• Volosin M, Song W, Almeida RD, Kaplan DR, Hempstead BL, Friedman WJ. Interaction of survival and death signaling in basal forebrain neurons: roles of neurotrophins and proneurotrophins. J Neurosci 2006; 26:7756 - 7766
   PubMed Web of Science ®Google Scholar
• Yaar M, Arble BL, Stewart KB, Qureshi NH, Kowall NW, Gilchrest BA. p75 (NTR) antagonistic cyclic peptide decreases the size of beta amyloid-Induced brain inflammation. Cell Mol Neurobiol 2008; 28:1027 - 1031
   PubMed Web of Science ®Google Scholar
• Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ. Beta-amyloid (1–42) induces neuronal death through the p75 neurotrophin receptor. J Neurosci 2008; 28:3941 - 3946
   PubMed Web of Science ®Google Scholar
• Ge YW, Lahiri DK. Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann NY Acad Sci 2002; 973:463 - 467
   PubMed Web of Science ®Google Scholar
• Rossner S, Ueberham U, Schliebs R, Perez-Polo JR, Bigl V. p75 and TrkA receptor signaling independently regulate amyloid precursor protein mRNA expression, isoform composition and protein secretion in PC12 cells. J Neurochem 1998; 71:757 - 766
   PubMed Web of Science ®Google Scholar
• Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, et al. M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update. Ann NY Acad Sci 1996; 777:189 - 196
   PubMed Web of Science ®Google Scholar
• Tatebayashi Y, Haque N, Tung YC, Iqbal K, Grundke-Iqbal I. Role of tau phosphorylation by glycogen synthase kinase-3beta in the regulation of organelle transport. J Cell Sci 2004; 117:1653 - 1663
   PubMed Web of Science ®Google Scholar
• Nuydens R, Dispersyn G, de Jong M, van den Kieboom G, Borgers M, Geerts H. Aberrant tau phosphorylation and neurite retraction during NGF deprivation in PC12 cells. Biochem Biophys Res Commun 1997; 240:687 - 691
   PubMed Web of Science ®Google Scholar
• Shelton SB, Johnson GV. Tau and HMW tau phosphorylation and compartmentalization in apoptotic neuronal PC12 cells. J Neurosci Res 2001; 66:203 - 213
   PubMed Web of Science ®Google Scholar
• Corsetti V, Amadoro G, Gentile A, Capsoni S, Ciotti MT, Cencioni MT, et al. Identification of a caspase-derived N-terminal tau fragment in cellular and animal Alzheimer's disease models. Mol Cell Neurosci 2008; 38:381 - 392
   PubMed Web of Science ®Google Scholar
• Amadoro G, Ciotti MT, Costanzi M, Cestari V, Calissano P, Canu N. NMDA receptor mediates tau-induced neurotoxicity by calpain and ERK/MAPK activation. Proc Natl Acad Sci USA 2006; 103:2892 - 2897
   PubMed Web of Science ®Google Scholar
• Babu JR, Geetha T, Wooten MW. Sequestosome 1/p62 shuttles polyubiquitinated tau for proteasomal degradation. J Neurochem 2005; 94:192 - 203
   PubMed Web of Science ®Google Scholar
• Niewiadomska G, Baksalerska-Pazera M, Riedel G. Altered cellular distribution of phospho-tau proteins coincides with impaired retrograde axonal transport in neurons of aged rats. Ann NY Acad Sci 2005; 1048:287 - 295
   PubMed Web of Science ®Google Scholar
• Niewiadomska G, Baksalerska-Pazera M, Riedel G. Cytoskeletal transport in the aging brain: focus on the cholinergic system. Rev Neurosci 2006; 17:581 - 618
   PubMed Web of Science ®Google Scholar
• Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, et al. Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen and skeletal muscle dystrophy. J Neurosci 2000; 20:2589 - 2601
   PubMed Web of Science ®Google Scholar
• Capsoni S, Cattaneo A. On the molecular basis linking nerve growth factor (NGF) to Alzheimer's disease. Cell Mol Neurobiol 2006; 26:619 - 633
   PubMed Web of Science ®Google Scholar
• Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, et al. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005; 11:551 - 555
   PubMed Web of Science ®Google Scholar
• Cattaneo A, Capsoni S, Paoletti F. Towards non invasive nerve growth factor therapies for Alzheimer's disease. J Alzheimers Dis 2008; 15:255 - 283
   PubMed Web of Science ®Google Scholar
• Matrone C, Di Luzio A, Meli G, D'Aguanno S, Severini C, Ciotti MT, et al. Activation of the amyloidogenic route by NGF deprivation induces apoptotic death in PC12 cells. J Alzheimers Dis 2008; 13:81 - 96
   PubMed Web of Science ®Google Scholar
• Matrone C, Ciotti MT, Mercanti D, Marolda R, Calissano P. NGF and BDNF signaling control amyloidogenic route and Ab production in hippocampal neurons. Proc Natl Acad Sci USA 2008; 105:13138 - 13143
   Web of Science ®Google Scholar
• Park DS, Morris EJ, Stefanis L, Troy CM, Shelanski ML, Geller HM, et al. Multiple pathways of neuronal death induced by DNA-damaging agents, NGF deprivation and oxidative stress. J Neurosci 1998; 18:830 - 840
   PubMed Web of Science ®Google Scholar
• Troy CM, Rabacchi SA, Hohl JB, Angelastro JM, Greene LA, Shelanski ML. Death in the balance: alternative participation of the caspase-2 and -9 pathways in neuronal death induced by nerve growth factor deprivation. J Neurosci 2001; 21:5007 - 5016
   PubMed Web of Science ®Google Scholar
• Perini G, Della-Bianca V, Politi V, Della Valle G, Dal-Pra I, et al. Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and synergistic effect of inflammatory cytokines. J Exp Med 2002; 195:907 - 918 Erratum in: J Exp Med 2002; 195:1231
   PubMed Web of Science ®Google Scholar
• Rametti A, Esclaire F, Yardin C, Terro F. Linking alterations in tau phosphorylation and cleavage during neuronal apoptosis. J Biol Chem 2004; 279:54518 - 54528
   PubMed Web of Science ®Google Scholar
• Bhat RV, Leonov S, Luthman J, Scott CW, Lee CM. Interactions between GSK3beta and caspase signalling pathways during NGF deprivation induced cell death. J Alzheimers Dis 2002; 4:291 - 330
   PubMedGoogle Scholar